Nephros Inc
(NEPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | |
| Cash Flows From Operating Activities | |
| Net Income | -7,590 |
| Depreciation Amortization | 190 |
| Other Working Capital | -1,230 |
| Other Operating Activity | 800 |
| Operating Cash Flow | $-7,830 |
| Cash Flows From Investing Activities | |
| PPE Investments | -900 |
| Other Investing Activity | -6,000 |
| Investing Cash Flow | $-6,900 |
| Cash Flows From Financing Activities | |
| Dividend Paid | -350 |
| Other Financing Activity | 14,630 |
| Financing Cash Flow | $14,280 |
| Exchange Rate Effect | 50 |
| Beginning Cash Position | 4,120 |
| End Cash Position | 3,710 |
| Net Cash Flow | $-400 |
| Free Cash Flow | |
| Operating Cash Flow | -7,830 |
| Free Cash Flow | -7,830 |